Similar articles

• Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia.

  Quasney MW, Waterer GW, Dahmer MK, Kron GK, Zhang Q, Kessler LA, Wunderink RG. Quasney MW, et al. Crit Care Med. 2004 May;32(5):1115-9. doi: 10.1097/01.ccm.0000124872.55243.5a. Crit Care Med. 2004. PMID: 15190959
• Against misleading predictions for severe community-acquired pneumonia.

  Ewig S. Ewig S. Am J Respir Crit Care Med. 2007 Feb 1;175(3):289; author reply 289-90. doi: 10.1164/ajrccm.175.3.289a. Am J Respir Crit Care Med. 2007. PMID: 17234911 No abstract available.
• Noninvasive ventilation routine therapy for community-acquired pneumonia? Not so fast!

  Hill NS. Hill NS. Intensive Care Med. 2001 May;27(5):797-9. doi: 10.1007/s001340100919. Intensive Care Med. 2001. PMID: 11430533 Free PMC article. No abstract available.
• Pneumonia as a systemic illness.

  Feldman C, Anderson R. Feldman C, et al. Curr Opin Pulm Med. 2018 May;24(3):237-243. doi: 10.1097/MCP.0000000000000466. Curr Opin Pulm Med. 2018. PMID: 29465465 Review.
• What is the association of cardiovascular events with clinical failure in patients with community-acquired pneumonia?

  Peyrani P, Ramirez J. Peyrani P, et al. Infect Dis Clin North Am. 2013 Mar;27(1):205-10. doi: 10.1016/j.idc.2012.11.010. Infect Dis Clin North Am. 2013. PMID: 23398875 Review.